NASDAQ:GLMD | Key Financial Ratios | Galmed Pharmaceuticals Ltd.

Complete source-backed ratio history.

Available history
2012-12-31 to 2026-06-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-06-304.16-62.04%-89.05%
2026-03-31-79.69%
2025-12-316.55-55.34%-65.32%
2025-09-307.98-40.31%-45.52%
2025-06-308.71-38.01%-42.50%
2025-03-31-43.53%
2024-12-317.42-40.63%-46.04%
2024-09-30-32.01%
2024-06-306.48-43.60%-49.35%
2024-03-31-66.10%
2023-12-314.81
2023-06-303.59-100.17%-126.02%
2023-03-31-167.66%
2022-12-314.76
2022-06-308.48-115.28%-131.22%
2022-03-31-118.90%
2021-12-316.13
2021-06-307.37-55.21%-64.20%
2021-03-31-46.57%
2020-12-316.47
2020-06-3013.62-29.68%-32.15%
2020-03-31-25.60%
2019-12-3111.02
2019-06-3025.69-15.10%-15.79%
2019-03-31-13.39%
2018-12-3133.41
2018-06-3024.84-12.86%-13.39%
2018-03-31-87.22%
2017-12-314.98
2017-06-302.59
2016-12-313.44
2016-06-305.12
2015-12-319.2
2014-12-3128.76
2013-12-310.09

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-12-316.55-55.34%-65.32%
2024-12-317.42-40.63%-46.04%
2023-12-314.81-41.57%-49.80%
2022-12-314.76-107.88%-133.10%
2021-12-316.13-88.70%-106.46%
2020-12-316.47-54.93%-65.16%
2019-12-3111.02-26.52%-29.29%
2018-12-3133.41-10.88%-11.21%
2017-12-314.98-62.61%-77.87%
2016-12-313.44-103.06%-153.07%
2015-12-319.2-43.78%-49.30%
2014-12-3128.76-27.65%-28.98%
2013-12-310.09-10533.13%896.21%
2012-12-31159.12%